Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Therapeutic blockade of HMGB1 reduces early motor deficits, but not survival in the SOD1G93A mouse model of amyotrophic lateral sclerosis.

Lee JD, Liu N, Levin SC, Ottosson L, Andersson U, Harris HE, Woodruff TM.

J Neuroinflammation. 2019 Feb 19;16(1):45. doi: 10.1186/s12974-019-1435-2.

2.

Neuroinflammation in Response to Intracerebral Injections of Different HMGB1 Redox Isoforms.

Aucott H, Lundberg J, Salo H, Klevenvall L, Damberg P, Ottosson L, Andersson U, Holmin S, Erlandsson Harris H.

J Innate Immun. 2018;10(3):215-227. doi: 10.1159/000487056. Epub 2018 Feb 23.

3.

Defibrillation before EMS arrival in western Sweden.

Claesson A, Herlitz J, Svensson L, Ottosson L, Bergfeldt L, Engdahl J, Ericson C, Sandén P, Axelsson C, Bremer A.

Am J Emerg Med. 2017 Aug;35(8):1043-1048. doi: 10.1016/j.ajem.2017.02.030. Epub 2017 Feb 16.

PMID:
28238537
4.

TLR4-dependant pro-inflammatory effects of HMGB1 on human adipocyte.

Gunasekaran MK, Virama-Latchoumy AL, Girard AC, Planesse C, Guérin-Dubourg A, Ottosson L, Andersson U, Césari M, Roche R, Hoareau L.

Adipocyte. 2016 Oct 10;5(4):384-388. eCollection 2016 Oct-Dec.

5.

A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug-induced liver injury and postinjury inflammation in mice.

Lundbäck P, Lea JD, Sowinska A, Ottosson L, Fürst CM, Steen J, Aulin C, Clarke JI, Kipar A, Klevenvall L, Yang H, Palmblad K, Park BK, Tracey KJ, Blom AM, Andersson U, Antoine DJ, Erlandsson Harris H.

Hepatology. 2016 Nov;64(5):1699-1710. doi: 10.1002/hep.28736. Epub 2016 Sep 1.

6.

Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.

Hoxha A, Ruffatti A, Ambrosi A, Ottosson V, Hedlund M, Ottosson L, Anandapadamanaban M, Sunnerhagen M, Sonesson SE, Wahren-Herlenius M.

Clin Exp Immunol. 2016 Dec;186(3):284-291. doi: 10.1111/cei.12854. Epub 2016 Sep 13.

7.

Scan-o-matic: High-Resolution Microbial Phenomics at a Massive Scale.

Zackrisson M, Hallin J, Ottosson LG, Dahl P, Fernandez-Parada E, Ländström E, Fernandez-Ricaud L, Kaferle P, Skyman A, Stenberg S, Omholt S, Petrovič U, Warringer J, Blomberg A.

G3 (Bethesda). 2016 Sep 8;6(9):3003-14. doi: 10.1534/g3.116.032342.

8.

Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.

Wirestam L, Schierbeck H, Skogh T, Gunnarsson I, Ottosson L, Erlandsson-Harris H, Wetterö J, Sjöwall C.

Arthritis Res Ther. 2015 Nov 23;17:338. doi: 10.1186/s13075-015-0856-2.

9.

Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus.

Kvarnström M, Dzikaite-Ottosson V, Ottosson L, Gustafsson JT, Gunnarsson I, Svenungsson E, Wahren-Herlenius M.

Lupus. 2013 Apr;22(5):477-85. doi: 10.1177/0961203313479420.

PMID:
23554036
10.

Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Yang H, Lundbäck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ.

Mol Med. 2012 Mar 30;18:250-9. doi: 10.2119/molmed.2011.00389.

11.

Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models.

Schierbeck H, Lundbäck P, Palmblad K, Klevenvall L, Erlandsson-Harris H, Andersson U, Ottosson L.

Mol Med. 2011 Sep-Oct;17(9-10):1039-44. doi: 10.2119/molmed.2010.00264. Epub 2011 Jun 7.

12.

Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block.

Strandberg LS, Ambrosi A, Jagodic M, Dzikaite V, Janson P, Khademi M, Salomonsson S, Ottosson L, Klauninger R, Adén U, Sonesson SE, Sunnerhagen M, de Graaf KL, Kuchroo VK, Achour A, Winqvist O, Olsson T, Wahren-Herlenius M.

J Immunol. 2010 Sep 15;185(6):3574-82. doi: 10.4049/jimmunol.1001396. Epub 2010 Aug 9.

13.

Sulfate assimilation mediates tellurite reduction and toxicity in Saccharomyces cerevisiae.

Ottosson LG, Logg K, Ibstedt S, Sunnerhagen P, Käll M, Blomberg A, Warringer J.

Eukaryot Cell. 2010 Oct;9(10):1635-47. doi: 10.1128/EC.00078-10. Epub 2010 Jul 30.

14.

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE.

J Leukoc Biol. 2009 Sep;86(3):655-62. doi: 10.1189/jlb.0908548. Epub 2009 Jun 29.

PMID:
19564572
15.

Robustness and fragility in the yeast high osmolarity glycerol (HOG) signal-transduction pathway.

Krantz M, Ahmadpour D, Ottosson LG, Warringer J, Waltermann C, Nordlander B, Klipp E, Blomberg A, Hohmann S, Kitano H.

Mol Syst Biol. 2009;5:281. doi: 10.1038/msb.2009.36. Epub 2009 Jun 16.

16.

Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies.

Strandberg L, Ambrosi A, Espinosa A, Ottosson L, Eloranta ML, Zhou W, Elfving A, Greenfield E, Kuchroo VK, Wahren-Herlenius M.

J Clin Immunol. 2008 May;28(3):220-31.

PMID:
18071879
17.

The Ile128Thr polymorphism influences stability and ligand binding properties of the microsomal triglyceride transfer protein.

Ledmyr H, Ottosson L, Sunnerhagen M, Ehrenborg E.

J Lipid Res. 2006 Jul;47(7):1378-85. Epub 2006 Apr 14.

18.

Structural organization and Zn2+-dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52.

Hennig J, Ottosson L, Andrésen C, Horvath L, Kuchroo VK, Broo K, Wahren-Herlenius M, Sunnerhagen M.

J Biol Chem. 2005 Sep 30;280(39):33250-61. Epub 2005 Jun 17.

19.

Structural, functional and immunologic characterization of folded subdomains in the Ro52 protein targeted in Sjögren's syndrome.

Ottosson L, Hennig J, Espinosa A, Brauner S, Wahren-Herlenius M, Sunnerhagen M.

Mol Immunol. 2006 Feb;43(6):588-98.

PMID:
15916807
20.

Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein.

Ottosson L, Salomonsson S, Hennig J, Sonesson SE, Dörner T, Raats J, Kuchroo VK, Sunnerhagen M, Wahren-Herlenius M.

Scand J Immunol. 2005 Feb;61(2):109-18.

21.

Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.

Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, Kuchroo VK, Thorén P, Herlenius E, Wahren-Herlenius M.

J Exp Med. 2005 Jan 3;201(1):11-7.

22.

A pH-induced modification of CII increases its arthritogenic properties.

Lundberg K, Ottosson L, Westman E, Sunnerhagen M, Hultenby K, Harris HE.

J Autoimmun. 2004 Sep;23(2):95-102.

PMID:
15324928
23.

Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block.

Salomonsson S, Ottosson L, Säfsten P, Hof D, Brauner H, Sunnerhagen M, Raats J, Wahren-Herlenius M.

J Autoimmun. 2004 Mar;22(2):167-77.

PMID:
14987746
24.
25.

[An unexpected verdict by the HSAN in a case of Achilles tendon rupture].

Ottosson L.

Lakartidningen. 1996 Dec 18;93(51-52):4712, 4715. Swedish. No abstract available.

PMID:
9011717
26.

Technical note--test instructions for the technical testing of mono-functional myoelectrically-controlled prosthetic hands. A proposal.

Ingvarsson B, Karlsson I, Ottosson LG, Thyberg M.

Prosthet Orthot Int. 1982 Apr;6(1):41-2.

PMID:
7079110
27.

Lateral instability of the ankle treated by a modified Evans procedure.

Ottosson L.

Acta Orthop Scand. 1978 Jun;49(3):302-5.

PMID:
685676
28.

Tilting table for patients in prone position.

Hansén B, Ottosson LG.

Scand J Rehabil Med. 1971;3(3):99-100. No abstract available.

PMID:
5156176
29.

Leg muscle strength in below-knee amputees.

Bäcklund L, Lemperg R, Ottosson LG.

Acta Orthop Scand. 1968;39(1):107-16. No abstract available.

PMID:
5730103
30.

Metastasis from carcinoma to carcinoma.

Ottosson L, Berge T.

Acta Pathol Microbiol Scand. 1968;73(4):481-8. No abstract available.

PMID:
5697606
31.

[Rehabilitation and cybernetics].

Fornstedt H, Ottosson LG.

Lakartidningen. 1967 Mar 8;64(10):993-6. Swedish. No abstract available.

PMID:
5585579
32.

[Femur head necroses and femur neck pseudarthroses--late results of non-surgical treatment].

Hiertonn T, Ottosson LG, Zachrisson B.

Lakartidningen. 1965 Sep 8;62(36):2833-46. Swedish. No abstract available.

PMID:
5869833
33.

[A MEANS OF GAIT ANALYSIS].

OTTOSSON LG.

Sven Lakartidn. 1964 Sep 30;61:2916-21. Swedish. No abstract available.

PMID:
14222122
34.

[PLAY THERAPY AS A PRELIMINARY EXERCISE TO PROSTHESIS TRAINING IN ABNORMALITIES OF THE EXTREMITIES].

OTTOSSON LG.

Sven Lakartidn. 1964 May 20;61:1678-91. Swedish. No abstract available.

PMID:
14146559
35.

[ON OCCUPATIONAL REHABILITATION IN ENGLAND].

OTTOSSON LG.

Sven Lakartidn. 1963 Dec 18;60:3840-51. Swedish. No abstract available.

PMID:
14103832
36.

[ON THE BRITISH HEALTH AND SICK-CARE SYSTEM--THE NATIONAL HEALTH SERVICE].

OTTOSSON LG.

Sven Lakartidn. 1963 Aug 28;60:2441-50. Swedish. No abstract available.

PMID:
14049216
37.

[Suggestion for a new form of administration for nose drops].

OTTOSSON LG.

Sven Farm Tidskr. 1963 May 10;67:371-2. Swedish. No abstract available.

PMID:
13940749

Supplemental Content

Loading ...
Support Center